0001682873-19-000002.txt : 20190103 0001682873-19-000002.hdr.sgml : 20190103 20190103130904 ACCESSION NUMBER: 0001682873-19-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181221 FILED AS OF DATE: 20190103 DATE AS OF CHANGE: 20190103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Danielsen Erik CENTRAL INDEX KEY: 0001682873 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12033 FILM NUMBER: 19504528 MAIL ADDRESS: STREET 1: 9900 CAVENDISH BLVD CITY: ST LAURENT STATE: A8 ZIP: H4M 2V2 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NYMOX PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0001018735 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9900 CAVENDISH BLVD., SUITE 306 STREET 2: ST. LAURENT CITY: QUEBEC CANADA STATE: A8 ZIP: H4M 2V2 BUSINESS PHONE: 1-800-936-9669 MAIL ADDRESS: STREET 1: 9900 CAVENDISH BLVD., SUITE 306 STREET 2: ST. LAURENT CITY: QUEBEC CANADA STATE: A8 ZIP: H4M 2V2 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2018-12-21 0 0001018735 NYMOX PHARMACEUTICAL CORP NYMX 0001682873 Danielsen Erik 9900 CAVENDISH BLVD ST LAURENT A8 H4M 2V2 QUEBEC, CANADA 0 1 0 0 CFO common stock 2018-12-21 4 P 0 6000 1.3475 A 20900 D Erick Danielsen 2019-01-03